Literature DB >> 26279067

Gene Therapy for Retinal Disease: What Lies Ahead.

Robert E MacLaren1.   

Abstract

Gene therapy in simple terms can be defined as a medical treatment that exerts its effects using molecules of DNA or RNA within cells. Most traditional drugs act by mechanisms that include binding to cell surface receptors, inhibiting enzymes in intracellular pathways or by modifying transcription. These approaches rely to some extent on a normal genetic make-up of the cell in the final common pathway, which raises significant challenges in diseases that are caused by specific gene mutations. An alternative gene therapy approach to change the behaviour of cells at the most fundamental level by one single genetic modification is therefore potentially very powerful and wide ranging. This paper presents an overview of retinal gene therapy at the current time and highlights the future therapeutic potential for a number of diseases that are currently incurable.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26279067     DOI: 10.1159/000438872

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina.

Authors:  Maria I Patrício; Alun R Barnard; Harry O Orlans; Michelle E McClements; Robert E MacLaren
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-31       Impact factor: 8.886

2.  The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A.

Authors:  Maria I Patrício; Alun R Barnard; Christopher I Cox; Clare Blue; Robert E MacLaren
Journal:  Mol Ther Methods Clin Dev       Date:  2018-03-28       Impact factor: 6.698

3.  Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy.

Authors:  Cathrine Jespersgaard; Mingyan Fang; Mette Bertelsen; Xiao Dang; Hanne Jensen; Yulan Chen; Niels Bech; Lanlan Dai; Thomas Rosenberg; Jianguo Zhang; Lisbeth Birk Møller; Zeynep Tümer; Karen Brøndum-Nielsen; Karen Grønskov
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

4.  Accurate Quantification of AAV Vector Genomes by Quantitative PCR.

Authors:  Cristina Martinez-Fernandez de la Camara; Michelle E McClements; Robert E MacLaren
Journal:  Genes (Basel)       Date:  2021-04-19       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.